Skip to Content

Bloxiverz FDA Approval History

FDA Approved: Yes (First approved May 31, 2013)
Brand name: Bloxiverz
Generic name: neostigmine methylsulfate
Dosage form: Injection
Company: Flamel Technologies
Treatment for: Reversal of Nondepolarizing Muscle Relaxants

Bloxiverz (neostigmine methylsulfate) is a cholinesterase inhibitor used for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery.

Development Timeline for Bloxiverz

DateArticle
Jun  3, 2013ApprovalFlamel Technologies Announces FDA Approval of Bloxiverz

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.